Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-10-12
1988-06-21
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Lymphokine
530324, A61K 3900, C07K 710
Patent
active
047524731
ABSTRACT:
Glycosylated polypeptides corresponding to antigenic portions of mature human influenza hemagglutinin are microbially produced in S. cerevisiae. The glycosylated polypeptides are effective as vaccination agents, since the glycosylated polypeptides closely minic the naturally occurring mature influenza hemagglutinin which is also glycosylated.
REFERENCES:
Nature 289, (1981), 366-373.
Nature 303, (1983), 41-44.
Hitzeman et al., Science, vol. 219, pp. 620-625, (2/83).
Kramer et al., Proc. Natl. Acad. Sci., vol. 81, pp. 367-370, (1/84).
Tuite et al., The Embo Journal, vol. I, No. 5, pp. 603-608, (1982).
Derynck et al., IRL Press Ltd., vol. II, No. 6, (1983), pp. 1819-1837.
Hitzeman et al., (1981), Nature (London), 293, 717-722.
Miyanohara et al., Proc. Natl. Acad. Sci., vol. 80, pp. 1-5, (1/83).
Goff et al., Gene, (1984), pp. 35-46.
Ammerer et al., Nature, vol. 298, (7/82), pp. 347-350.
Mellor et al., Gene, (1983), pp. 1-14.
Jabbar M. Abdul
Nayak Debi P.
Phillips Delbert R.
The Regents of the University of California
LandOfFree
Expression of glycosylated human influenza hemagglutinin protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression of glycosylated human influenza hemagglutinin protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression of glycosylated human influenza hemagglutinin protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-928913